Should sodium-glucose co-transporter-2 inhibitors be considered as first-line oral therapy for people with type 2 diabetes?
| Image |  |
|---|---|
| Description | scientific article published on 03 October 2018 |
| Author/s |
author: Samuel Seidu Kamlesh Khunti Melanie Davies |
| Publication date | October 3, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |